PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran,Iran.\', \'Gastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, ,Iran.\', \'Department of Anesthesiology and Critical Care, Qom University of Medical Sciences, Qom, ,Iran.\', \'MSc in Health Information Technology, Health Information Technology, Tehran University of Medical Science, Tehran, ,Iran.\', \'Assistant Professor of Nuclear Pharmacy, Gastroenterology and Hepatology Diseases Research Center, Qom University of Medical Sciences, Qom, ,Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2174/1871526521666210218201601
?:doi
?:hasPublicationType
?:journal
  • Infectious disorders drug targets
is ?:pmid of
?:pmid
?:pmid
  • 33602079
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Hepatic Involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all